AMW GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Summary

AMW GmbH (AMW) is a specialty pharmaceutical company with focus on drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. AMW designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable subcutaneous implants for the treatment of various hormone responding tumors, chronic pain (neurological) and psychiatric diseases. Its major products for licensing include Goserelin implant, Leuprorelin implant, Buprenorphin patch and Rivastigmin patch. AMW is also developing Rotigotin patch and patch for the treatment of breast cancer. The company developed new patented technologies for the active control of drug releasing pharmaceuticals. It conducts analytical investigations in state-of-the-art GMP-approved laboratories. AMW is headquartered in Warngau, Germany.

AMW GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

2
List of Tables 3
List of Figures 4
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AMW GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AMW GmbH, Medical Devices Deals, 2011 to YTD 2017 9
AMW GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AMW GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
AMW Raises USD9 Million in Venture Financing 11
AMW Raises Funds in Venture Financing 12
AMW Raises Funds in Third Round of Financing 13
AMW Raises Funds in Second Round of Financing 13
AMW GmbH - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


AMW GmbH, Pharmaceuticals & Healthcare, Key Facts 1
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AMW GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AMW GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
AMW GmbH, Medical Devices Deals, 2011 to YTD 2017 9
AMW GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AMW Raises USD9 Million in Venture Financing 11
AMW Raises Funds in Venture Financing 12
AMW Raises Funds in Third Round of Financing 13
AMW Raises Funds in Second Round of Financing 13
AMW GmbH, Key Competitors 15
AMW GmbH, Key Employees 16

List Of Figures


AMW GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AMW GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AMW GmbH, Medical Devices Deals, 2011 to YTD 2017 9

Softship GmbH - Strategic SWOT Analysis Review

Softship GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on

USD 125 View Report

Giesecke+Devrient GmbH - Strategy, SWOT and Corporate Finance Report

Giesecke+Devrient GmbH - Strategy, SWOT and Corporate Finance ReportGiesecke+Devrient GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available